Itochu takes minority stake in AI drug discovery firm Molcure

PUBT · 3d ago
Itochu takes minority stake in AI drug discovery firm Molcure
  • Itochu signed a capital alliance agreement with Molcure to take a minority equity stake.
  • Deal targets AI-driven drug discovery for antibodies and peptides, linking Molcure’s platform with Itochu’s clinical development network.
  • Partnership aims to offer end-to-end support from AI-led candidate creation to preclinical and clinical development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Itochu Corporation published the original content used to generate this news brief on October 07, 2026, and is solely responsible for the information contained therein.